Race Oncology Limited

ASX:RAC Stock Report

Market Cap: AU$241.2m

Race Oncology Future Growth

Future criteria checks 2/6

Race Oncology is forecast to grow earnings and revenue by 0.1% and 34.8% per annum respectively while EPS is expected to decline by 40.2% per annum.

Key information

0.1%

Earnings growth rate

-40.2%

EPS growth rate

Biotechs earnings growth15.6%
Revenue growth rate34.8%
Future return on equityn/a
Analyst coverage

Low

Last updated17 Dec 2024

Recent future growth updates

Recent updates

Is Race Oncology (ASX:RAC) In A Good Position To Deliver On Growth Plans?

Aug 26
Is Race Oncology (ASX:RAC) In A Good Position To Deliver On Growth Plans?

We Think Race Oncology (ASX:RAC) Needs To Drive Business Growth Carefully

May 10
We Think Race Oncology (ASX:RAC) Needs To Drive Business Growth Carefully

We're Not Very Worried About Race Oncology's (ASX:RAC) Cash Burn Rate

Jan 23
We're Not Very Worried About Race Oncology's (ASX:RAC) Cash Burn Rate

Here's Why We're Not Too Worried About Race Oncology's (ASX:RAC) Cash Burn Situation

Oct 05
Here's Why We're Not Too Worried About Race Oncology's (ASX:RAC) Cash Burn Situation

Companies Like Race Oncology (ASX:RAC) Are In A Position To Invest In Growth

Jun 20
Companies Like Race Oncology (ASX:RAC) Are In A Position To Invest In Growth

We're Interested To See How Race Oncology (ASX:RAC) Uses Its Cash Hoard To Grow

Feb 17
We're Interested To See How Race Oncology (ASX:RAC) Uses Its Cash Hoard To Grow

Here's Why We're Not At All Concerned With Race Oncology's (ASX:RAC) Cash Burn Situation

Oct 14
Here's Why We're Not At All Concerned With Race Oncology's (ASX:RAC) Cash Burn Situation

Here's Why We're Not Too Worried About Race Oncology's (ASX:RAC) Cash Burn Situation

Apr 01
Here's Why We're Not Too Worried About Race Oncology's (ASX:RAC) Cash Burn Situation

We're Hopeful That Race Oncology (ASX:RAC) Will Use Its Cash Wisely

Apr 05
We're Hopeful That Race Oncology (ASX:RAC) Will Use Its Cash Wisely

What Percentage Of Race Oncology Limited (ASX:RAC) Shares Do Insiders Own?

Mar 01
What Percentage Of Race Oncology Limited (ASX:RAC) Shares Do Insiders Own?

How Much Are Race Oncology Limited (ASX:RAC) Insiders Taking Off The Table?

Jan 07
How Much Are Race Oncology Limited (ASX:RAC) Insiders Taking Off The Table?

Earnings and Revenue Growth Forecasts

ASX:RAC - Analysts future estimates and past financials data (AUD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202711-7-6-61
6/30/20263-27-27-271
6/30/20255-6-6-61
6/30/20244-14-10-10N/A
3/31/20245-12-11-11N/A
12/31/20236-11-13-13N/A
9/30/20234-11-12-12N/A
6/30/20233-10-11-11N/A
3/31/20232-10-10-10N/A
12/31/20221-11-9-9N/A
9/30/20221-11-8-8N/A
6/30/20221-11-6-6N/A
3/31/20221-10-6-6N/A
12/31/20211-9-6-6N/A
9/30/20211-8-5-5N/A
6/30/20210-6-5-5N/A
3/31/20210-5-4-4N/A
12/31/20200-4-3-3N/A
9/30/20200-4-3-3N/A
6/30/20200-4-2-2N/A
3/31/20200-3-2-2N/A
12/31/20190-3-2-2N/A
9/30/20190-3-2-2N/A
6/30/20190-4-3-3N/A
3/31/20190-4-3-3N/A
12/31/20180-5-3-3N/A
9/30/20180-6-3-3N/A
6/30/20180-6-4-4N/A
3/31/20180-6N/A-4N/A
12/31/20170-6N/A-4N/A
9/30/20170-5N/A-3N/A
6/30/2017N/A-4N/A-2N/A
3/31/2017N/A-3N/A-2N/A
12/31/2016N/A-2N/A-1N/A
9/30/2016N/A-1N/A-1N/A
6/30/2016N/A0N/A0N/A
3/31/2016N/A0N/A0N/A
12/31/2015N/A0N/A0N/A
9/30/2015N/A0N/A0N/A
6/30/2015N/A0N/A0N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: RAC is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: RAC is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: RAC is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: RAC's revenue (34.8% per year) is forecast to grow faster than the Australian market (5.8% per year).

High Growth Revenue: RAC's revenue (34.8% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if RAC's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 05:04
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Race Oncology Limited is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullIndependent Investment Research (Aust.) Pty Ltd
Chris KallosMST Financial Services Pty Limited